Treatment of B-cell Acute Lymphoblastic Leukemia and B-cell Lymphoma / 대한소아혈액종양학회지
Korean Journal of Pediatric Hematology-Oncology
;
: 166-176, 2002.
Artigo
em Coreano
| WPRIM
| ID: wpr-13142
ABSTRACT
PURPOSE:
We report here the improved survival rate of B-cell acute lymphoblstic leukemia (B-ALL) and B-cell non-Hodgkin's lymphoma (B-NHL) treated with a short, intensive multiagent chemotherapy and the treatment related toxicities and complications.METHODS:
From Oct. 1997 to Apr. 2002, 10 patients were enrolled. Patients were classified into three groups (Group A, B, C) according to tumor burden and were treated with CCG 5961, UKCCSG 9600, and LMB96 protocol. Induction chemotherapy included cyclophsophamide, vincristine, prednisolone, doxorubicin and high dose (HD) methotrexate (COPADM). Consolidation chemotherapy included HD methotrexate, HD cytarabine and etoposide (CYM; group B, CYVE; group C). In one patient, HD chemotherapy with stem cell rescue was used because residual disease was detected after consolidation chemotheapy.RESULTS:
Four patients were B-ALL and six patients were B-NHL (A; 1, B; 2, C; 7). Regimen was changed in 1 patient because of residual disease (B--CONCLUSION:
This study confirms the effectiveness of short, intensive multiagent chemotherapy and we suggest early detection and management of toxic complication is the cornerstone of successful therapy.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Recidiva
/
Células-Tronco
/
Estomatite
/
Vincristina
/
Medula Óssea
/
Linfoma não Hodgkin
/
Prednisolona
/
Linfócitos B
/
Síndrome de Lise Tumoral
/
Leucemia
Tipo de estudo:
Guia de Prática Clínica
/
Estudo observacional
/
Estudo prognóstico
/
Estudo de rastreamento
Limite:
Humanos
Idioma:
Coreano
Revista:
Korean Journal of Pediatric Hematology-Oncology
Ano de publicação:
2002
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS